北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (6): 937-941. doi: 10.3969/j.issn.1671-167X.2016.06.003

• 论著 • 上一篇    下一篇

抗瓜氨酸化葡萄糖-6-磷酸异构酶多肽抗体的检测及其在类风湿关节炎中的意义

武东,孙琳,李常虹,杨麟,赵金霞△,刘湘源△   

  1. (北京大学第三医院风湿免疫科, 北京100191)
  • 出版日期:2016-12-18 发布日期:2016-12-18
  • 通讯作者: 赵金霞,刘湘源 E-mail: zhao-jinxia@163.com, liu-xiangyuan@263.net
  • 基金资助:

    国家自然科学基金(81571573)资助

Significance of antibodies to the citrullinated glucose-6-phosphate isomerase peptides in rheumatoid arthritis

WU Dong, SUN Lin, LI Changhong, YANG Lin, ZHAO Jinxia△, LIU Xiangyuan△   

  1. (Department of Rheumatology & Immunology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2016-12-18 Published:2016-12-18
  • Contact: ZHAO Jin-xia, LIU Xiang-yuan E-mail: zhao-jinxia@163.com, liu-xiangyuan@263.net
  • Supported by:

    Supported by the National Natural Science Foundation of China (81571573)

摘要:

目的:检测类风湿关节炎(rheumatoid arthritis,RA)患者血清中抗瓜氨酸化葡萄糖-6-磷酸异构酶(citrullinated glucose-6-phosphate isomerase,C-GPI)70~88肽抗体(抗C-GPI70~88抗体)和抗C-GPI 435~453肽抗体(抗C-GPI435~453抗体)的水平,同时检测其原型多肽抗体水平,评价抗C-GPI多肽抗体在RA诊断中的价值。方法: 应用酶联免疫吸附法检测191例RA患者、129例其他风湿免疫疾病患者和74例健康对照组血清中抗C-GPI70~88抗体、抗C-GPI435~453抗体、抗GPI70~88抗体和抗GPI435~453抗体的水平,并收集RA患者临床和实验室检查数据,分析抗C-GPI多肽抗体在RA诊断中的价值以及与临床和实验室指标的相关性。结果: (1)RA组抗C-GPI70~88抗体和抗C-GPI435~453抗体的滴度(68.71±4.20和51.78±3.13)显著高于疾病对照组和健康对照组(P<0.05),而抗GPI70~88抗体和抗GPI435~453抗体的滴度在各组中差异无统计学意义。(2)抗C-GPI70~88抗体在RA诊断中的敏感性为41.88%,特异性为84.50%;抗C-GPI435~453抗体在RA诊断中的敏感性为46.05%,特异性为86.05%;联合检测两种抗瓜氨酸化多肽抗体的敏感性为50.79%,特异性为86.05%。(3)抗C-GPI70~88抗体和抗C-GPI435~453抗体在类风湿因子、抗角蛋白抗体、抗环瓜氨酸肽抗体均阴性的RA患者中的阳性率分别为35.00%和45.00%。(4)RA患者抗C-GPI70~88抗体和抗C-GPI435~453抗体阳性组和阴性组之间临床和实验室指标差异无统计学意义。结论: RA患者体内可以检测到抗C-GPI多肽抗体,C-GPI可能参与了RA的发病,对于血清阴性的RA患者有较好的诊断价值。

关键词: 关节炎, 类风湿, 瓜氨酸化, 葡萄糖-6-磷酸异构酶

Abstract:

Objective: To detect the anti-citrullinated glucose-6-phosphate isomerase (GPI) 70-88 peptide antibody(anti-C-GPI70-88 antibody),anti-citrullinated GPI 435-453 peptide antibody(anti-C-GPI435-453 antibody), anti-GPI 70-88 peptide antibody(anti-GPI70-88 antibody) and anti-GPI 435-453 peptide antibody(anti-GPI435-453 antibody) in the serum of rheumatoid arthritis(RA) patients,and exa-mine the diagnostic values of the anti-C-GPI peptide antibodies in RA. Methods: The anti-C-GPI70-88 antibody, anti-C-GPI435-453 antibody, anti-GPI70-88 antibody and anti-GPI435-453 antibody were detected by enzyme-linked immunosorbent assay(ELISA) in 191 RA patients,129 other rheumatic diseases and 74 healthy controls. The clinical and laboratory data of the patients with RA were collected, and the values of anti-C-GPI peptide antibodies in the diagnosis of RA and the relationships of anti-C-GPI peptide antibodies with the clinical and laboratory parameters analyzed. Results: (1)The mean titers of the anti-C-GPI70-88 antibody and the anti-C-GPI435-453 antibody in the RA patients (respectively, 68.71±4.20 and 51.78±3.13) were significantly higher than those with other rheumatic diseases and healthy individuals(P<0.05). However,the mean titers of the anti-GPI70-88 antibody and anti-GPI435-453  antibody in the RA patients were similar to those with other rheumatic diseases and healthy individuals.(2)The diagnostic sensitivity and specificity of the anti-C-GPI70-88 antibody for RA were 41.88% and 84.50% respectively; and the diagnostic sensitivity and specificity of the anti-C-GPI435-453 antibody for RA were 46.05% and 86.05% respectively.The sensitivity of combined detection of the two anti-C-GPI peptide antibodies was 50.79%, and the specificity was 81.40%. (3) The positive rates of the anti-C-GPI70-88 antibody and the anti-C-GPI435-453 antibody were 35% and 45% respectively in those patients with negative anticyclic citrullinated peptide antibody, antikeratin antibody, and rheumatoid factor. (4) There was no significant difference in clinical and laboratory indicators between the anti-C-GPI70-88 antibody or anti-C-GPI435-453 antibody positive group and negative group. Conclusion: The anti-C-GPI70-88 antibody and anti-C-GPI435-453  antibody can be detected in the serum of RA patients, and C-GPI may be involved in the pathogenesis of RA. There is a certain diagnostic significance for the sera-negative RA.

Key words: Arthritis, rheumatoid, Citrulline, Glucose-6-phosphate isomerase

中图分类号: 

  • R593.22
[1] 刘东武, 陈杰, 高明利, 于静. 类风湿关节炎伴发淋巴结Castleman样病理改变1例[J]. 北京大学学报(医学版), 2024, 56(5): 928-931.
[2] 李正芳,罗采南,武丽君,吴雪,孟新艳,陈晓梅,石亚妹,钟岩. 抗氨基甲酰化蛋白抗体在诊断类风湿关节炎中的应用价值[J]. 北京大学学报(医学版), 2024, 56(4): 729-734.
[3] 黄会娜,赵静,赵祥格,白自然,李霞,王冠. 乳酸对类风湿关节炎患者外周血CD4+T细胞亚群的调控作用[J]. 北京大学学报(医学版), 2024, 56(3): 519-525.
[4] 汤晓菲,李永红,丁秋玲,孙卓,张阳,王育梅,田美伊,刘坚. 类风湿关节炎患者下肢深静脉血栓发病率及危险因素[J]. 北京大学学报(医学版), 2024, 56(2): 279-283.
[5] 李红光,韩玮华,吴训,冯继玲,李刚,孟娟红. 关节腔冲洗联合液态浓缩生长因子注射治疗单侧颞下颌关节骨关节炎的初步研究[J]. 北京大学学报(医学版), 2024, 56(2): 338-344.
[6] 邹雪,白小娟,张丽卿. 艾拉莫德联合托法替布治疗难治性中重度类风湿关节炎的疗效[J]. 北京大学学报(医学版), 2023, 55(6): 1013-1021.
[7] 吴琦,蔡月明,何娟,黄文蒂,王庆文. 血脂异常与类风湿关节炎肺间质病变的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 982-992.
[8] 张警丰,金银姬,魏慧,姚中强,赵金霞. 体重指数与类风湿关节炎临床特征的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 993-999.
[9] 金银姬,孙琳,赵金霞,刘湘源. 血清IgA型抗鼠科肉瘤病毒癌基因同源物B1抗体在类风湿关节炎中的意义[J]. 北京大学学报(医学版), 2023, 55(4): 631-635.
[10] 蔡文心,李仕成,刘一鸣,梁如玉,李静,郭建萍,胡凡磊,孙晓麟,李春,刘栩,叶华,邓立宗,李茹,栗占国. 类风湿关节炎临床分层及其特征的横断面研究[J]. 北京大学学报(医学版), 2022, 54(6): 1068-1073.
[11] 程昉,杨邵英,房星星,王璇,赵福涛. CCL28-CCR10通路在类风湿关节炎单核细胞迁移中的作用[J]. 北京大学学报(医学版), 2022, 54(6): 1074-1078.
[12] 刘蕊,赵金霞,闫良. 类风湿关节炎合并下肢静脉血栓患者的临床特点[J]. 北京大学学报(医学版), 2022, 54(6): 1079-1085.
[13] 张警丰,金银姬,魏慧,姚中强,赵金霞. 类风湿关节炎患者生活质量与疾病活动度的横断面研究[J]. 北京大学学报(医学版), 2022, 54(6): 1086-1093.
[14] 徐朝焰,林长艺,叶达梅,吴培埕,宋明辉,刘有添,邓琼,黄雪艳,范忠晓,游雪兰. 感染性关节炎诊断分析[J]. 北京大学学报(医学版), 2022, 54(6): 1234-1237.
[15] 栗占国,任立敏. 侵蚀性骨关节炎:一种值得关注的疾病[J]. 北京大学学报(医学版), 2022, 54(5): 829-831.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!